secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENDRA Life Sciences Inc. (NDRA)
CIK:        0001681682
Form:       8-K
Filed at:   2022-12-02T23:59:59+00:00
Accession:  0001654954-22-016066
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ENDRA Life Sciences shareholders approve reverse stock split; board sets 1-for-20 ratio
--------------------------------------------------------------------------------

- Shareholders approved amendment to authorize reverse stock split at ratio from 1-for-2 to 1-for-30.
- Board of Directors set the final ratio at 1-for-20 after the special meeting.
- Company intends to effect the reverse split before December 31, 2022.
- Vote results: 21,057,265,393 for, 7,433,237,535 against, 5,832,047,971 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681682/000165495422016066/0001654954-22-016066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681682/000165495422016066/endra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-016066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer